VolitionRX Ltd. (VNRX)
0.235
0.00 (0.00%)
USD |
NYAM |
Oct 02, 16:00
0.2332
0.00 (0.00%)
After-Hours: 20:00
VolitionRX Enterprise Value : 10.08M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 10.08M |
| October 01, 2026 | 10.07M |
| September 30, 2026 | 10.35M |
| September 29, 2026 | 10.33M |
| September 28, 2026 | 10.29M |
| September 25, 2026 | 10.36M |
| September 24, 2026 | 10.21M |
| September 23, 2026 | 10.22M |
| September 22, 2026 | 10.42M |
| September 21, 2026 | 10.44M |
| September 18, 2026 | 10.38M |
| September 17, 2026 | 10.68M |
| September 16, 2026 | 10.56M |
| September 15, 2026 | 10.73M |
| September 14, 2026 | 11.00M |
| September 11, 2026 | 10.98M |
| September 10, 2026 | 11.34M |
| September 09, 2026 | 11.36M |
| September 08, 2026 | 11.25M |
| September 04, 2026 | 11.46M |
| September 03, 2026 | 11.46M |
| September 02, 2026 | 11.78M |
| September 01, 2026 | 11.99M |
| August 31, 2026 | 12.47M |
| August 28, 2026 | 12.66M |
| Date | Value |
|---|---|
| August 27, 2026 | 13.28M |
| August 26, 2026 | 11.33M |
| August 25, 2026 | 11.88M |
| August 24, 2026 | 11.95M |
| August 21, 2026 | 12.27M |
| August 20, 2026 | 12.60M |
| August 19, 2026 | 13.12M |
| August 18, 2026 | 12.96M |
| August 17, 2026 | 13.27M |
| August 14, 2026 | 13.72M |
| August 13, 2026 | 14.84M |
| August 12, 2026 | 15.30M |
| August 11, 2026 | 15.86M |
| August 10, 2026 | 16.48M |
| August 07, 2026 | 16.58M |
| August 06, 2026 | 16.47M |
| August 05, 2026 | 16.82M |
| August 04, 2026 | 16.70M |
| August 03, 2026 | 16.88M |
| July 31, 2026 | 15.89M |
| July 30, 2026 | 16.88M |
| July 29, 2026 | 16.55M |
| July 28, 2026 | 17.50M |
| July 27, 2026 | 17.84M |
| July 24, 2026 | 19.29M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IDEXX Laboratories, Inc. | 41.79B |
| Neogen Corp. | 3.272B |
| QuidelOrtho Corp. | 3.688B |
| Aspira Women's Health, Inc. | 13.72M |
| Lucid Diagnostics, Inc. | 111.17M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.775M |
| Revenue (Quarterly) | 0.3987M |
| Total Expenses (Quarterly) | 8.185M |
| EPS Diluted (Quarterly) | -0.8505 |
| Gross Profit Margin (Quarterly) | 28.37% |
| Profit Margin (Quarterly) | -1.95K% |
| Earnings Yield | -1.63K% |
| Normalized Earnings Yield | -1524.47 |